Sinus Dilation Devices Market Size, Share, and COVID-19 Impact Analysis By Product (Balloon Sinus Dilation Devices, Endoscopes, Sinus Stents/Implants, and Others), By Patient Type (Adult and Pediatric), By End-User (Hospitals & ASCs, ENT Clinics (In-Office), and Others) and Regional Forecast, 2025-2032

The global burden of chronic sinusitis is rapidly increasing across the globe. Sinus dilation devices are crucial in managing chronic sinusitis patients. Over the years, several advancements in technology and techniques have been used to relieve sinus pain. With the advancements in camera and telescopic devices, the sinus dilation devices market space is expected to witness considerable growth in the coming years. Moreover, the introduction of surgical laser technologies in sinus surgery has resulted in fewer side effects & and ensured minimal ablation.

Furthermore, the rising prevalence of chronic as well as acute sinusitis is increasing the demand for sinus dilation devices. According to Centers for Disease Control and Prevention (CDC) data, the number of adults with diagnosed sinusitis in the U.S. was 28.9 million in 2018. The same source further stated that the number of physician visits with chronic sinusitis as the primary diagnosis was 2.7 million in 2018.

Impact of COVID-19 on the Global Sinus Dilation Devices Market

The recent outbreak of the COVID-19 pandemic had a negative impact on the global sinus dilation devices market. There was a multitude of factors that negatively impacted the market growth in that period. Some of the factors that negatively impacted the market growth included the decline in the number of sinus dilation procedures, canceled elective surgeries & routine clinic visits, and redirecting the available healthcare capacities and resources toward COVID-19 management.

• For instance, as per the article published by the National Center for Biotechnology Information (NCBI) in September 2020, during the first month of the COVID-19 pandemic, the ENT surgical volume witnessed a reduction of 84% in France.

Moreover, ENT specialists and surrounding staff were at a high risk of contracting the infection as they were in direct contact with virus-contracting particles during clinical examination, surgeries, or other interventions in the head and neck area. Thus, the convergence of these factors resulted in a decline in revenue generation of sinus dilation devices during the pandemic.

Key Insights

The report will cover the following key insights:

• Overview of Epidemiology of Sinusitis, 2022
• Technological Advancements in Sinus Dilation Surgery Devices
• Key Industry Developments -Mergers, Acquisitions, and Partnerships
• New Product Launches
• Impact of COVID-19 on the Global Sinus Dilation Devices Market

Analysis by Product

The balloon sinus dilation devices segment captured a significant share of the global sinus dilation devices market. These devices are considered to be safe, flexible, and effective in the management of sinusitis symptoms. Some of the benefits of balloon sinus dilation over traditional surgery include a lower risk of bleeding, faster recovery time, reduced risk of post-op infection, fewer post-op appointments, and others. As the balloon dilation procedure does not involve tissue ablation, it results in increased patient comfort leading to increasing adoption in the market. Moreover, technological advancements in these devices and processes further boost the segment revenue generation.

Regional Analysis

To gain extensive insights into the market, Download for Customization

North America is anticipated to dominate the global sinus dilation devices market in 2022. The key factors contributing to the regional dominance include the high prevalence of chronic sinusitis, the presence of well-established players & their initiatives to expand their product offerings in the region, and the well-developed healthcare infrastructure.

• For instance, According to Centers for Disease Control and Prevention (CDC) data, the number of visits to emergency departments with chronic sinusitis as the primary diagnosis in the U.S. was 234,000 in 2018. Additionally, percent of adults with diagnosed sinusitis in the U.S. was 11.6% of the total population.

Thus, this high number of individuals with diagnosed sinusitis is expected to increase the demand for sinus dilation devices in the region by increasing the number of surgeries for sinus dilation.

Furthermore, other factors such as increasing adoption of minimally invasive surgeries for sinusitis, availability of advanced products, and increasing awareness regarding sinus dilation procedures have also supplemented the regional market growth.

Key Players Covered

The report will include profiles of key players such as Stryker, Olympus, Medtronic, SinuSys Corporation, Intersect ENT Inc., Johnson & Johnson Services, Inc. (Acclarent, Inc.), Creganna, InnAccel, Optim LLC, and Dalent Medical.

Segmentation

Key Industry Developments

• June 2022: Medtronic completed the acquisition of Intersect ENT Inc. to expand its offerings in the ear, nose, and throat (ENT) segment. This acquisition included SINUVA and PROPEL sinus implant product lines and technology.
• March 2022: an ENT surgeon from India along with a team of engineers developed an indigenous silicon implant to suit the needs of the nose of Asians especially Indians.